ENDO Press Conference Archives

ENDO 2017

News Conference on Endocrine-Disrupting Chemicals

Saturday, April 1 at 10am || Studies Presented:
  • Pyrethroid pesticide exposure appears to speed puberty in boys
  • Exposure to BPA substitute, BPS, multiplies breast cancer cells
  • Exposure to common flame retardants may raise the risk of papillary thyroid cancer
  • Early-life BPA exposure reprograms gene expression linked to fatty liver

 

News Conference on Thyroid Health

Saturday, April 1 at 11am || Studies Presented:
  • People with higher thyroid hormone levels may be at greater risk for atherosclerosis
  • Recent thyroid cancer trends in the United States suggest age and racial disparities
  • Concurrent milk ingestion decreases oral levothyroxine absorption

 

News Conference on Men’s Health

Monday, April 3 at 10am || Studies Presented:
  • Hormones are behind hernias of the groin in elderly men, study suggests
  • Effects of the human fetal estrogen estetrol (E4) in Healthy Men to treat prostate cancer
  • Higher anabolic hormone levels predict lower risk of worsening frailty in men

 

News Conference on Technologies to Treat Obesity and Diabetes

Monday, April 3 at 11 am || Studies Presented:
  • Artificial Pancreas Improves Blood Sugar Control in Young Kids
  • Virtual clinics help rural primary care providers to manage complex diabetes
  • Deep Transcranial Magnetic Stimulation (dTMS) Exerts Anti-Obesity Effects Via Microbiota Modulation

 

News Conference on Obesity

Tuesday, April 4 at 10 am – Studies Presented:
  • Participation in a weight management program reduces job absenteeism
  • Inhaled corticosteroids may raise women’s risk of the metabolic syndrome
  • Vitamin D deficiency may indicate CVD in overweight and obese children

 

ENDO 2016 Press Conference Recap

  • Friday, April 1
    Women’s Health: The Society released its Scientific Statement on compounded bioidentical hormones used to treat menopausal symptoms and other hormone conditions during this event. The press conference also featured research to engineer new implanted devices to treat infertility, investigate the link between polycystic ovary syndrome (PCOS) and asthma, and develop a new method to predict post-menopausal bone loss.
    Endocrine-disrupting Chemicals
    : This session examined the effect of endocrine-disrupting chemical exposure on the microbiome, attention deficit disorders in children, male fertility, and developing breast tissue and potential cancer risk.
  • Saturday, April 2
    Diabetes
    : The press conference delved into how the diabetes drug liraglutide affects the brain and appetite, the best breakfast proteins for people with diabetes, and the connection between thyroid disorders and Type 2 diabetes.
    Obesity
    : Researchers discussed studies comparing the Paleolithic diet to a low-fat diet, early signs of childhood obesity in infants, and patterns of weight loss and gain in a large population study.
  • Sunday, April 3
    Bone Health
    : Researchers shared new insights on the effects of attention-deficit hyperactivity disorder medications and anti-depressants on bone health.

ENDO 2015 Press Conference Recap

  • Thursday, March 5
    Endocrine-Disrupting Chemicals: New findings on the economic costs of endocrine-disrupting chemical (EDC) exposure, the link between household chemical exposure in the womb and autistic features, the multi-generational impact of PCB exposure, and the connection between phthalates and male birth defects.
    Obesity: New insights into how male obesity affects a couple’s fertility, a nasal spray that may reduce calorie consumption, and the evolution of gut microbiota in men who have prediabetes.
    Diet: The latest findings on how eating nuts can reduce the risk of developing metabolic syndrome, the benefits of lowering fructose consumption, a comparison of diets that restrict fats and carbohydrates, and the health effects of genetically modified soybean oil.
  • Friday, March 6
    Hormones and Aging: New research into trends in menopausal hormone therapy, the long-term safety of menopausal hormone therapy, and the connection between low testosterone and mental health.
  • Saturday, March 7
    Thyroid Health: Promising work on thyroid cancer-sniffing dogs, the rate of thyroid cancer diagnosis in breast cancer survivors, and an experimental drug that burns fat cells by activating thyroid hormone receptors.

ICE/ENDO 2014 Press Conference Recap

  • Saturday, June 21
    Pregnancy and Hormones: The latest research on a new test predicting risk of miscarriage, effects of maternal anti-depressant use on offspring, and benefits of dietary and lifestyle changes made early in pregnancy.
  • Sunday, June 22
    Diabetes: Promising work on the benefits of vitamin D and soy supplements for patients with diabetes, the link between taste buds and high fasting glucose levels, and a diabetes device not being used to its full potential.
  • Monday, June 23
    Endocrine-Disrupting Chemicals: New findings on the health impacts of exposure to chemicals like BPA, BPA-like chemical BPS and the hormone-disrupting effects of chemicals used in fracking.
    Obesity: New insights into how microbes in the gut may signal diabetes risk, a look at a new weight loss pill, and new information about weight-loss methods that most satisfy American obese patients.
  • Tuesday, June 24
    Weight Loss: New research on the effects of weight loss on sleep and mood, and new findings assessing weight loss surgery vs. medical weight management in obese patients.

Read more about the research presented in the Society's press releases.

ENDO 2013 Press Conference Recap

  • Saturday, June 15
    Adolescent Health: New insights into how hormones can be used to help teens with conditions including eating disorders and gender identity disorder.
  • Sunday, June 16
    Obesity: The latest research into factors that may contribute to obesity, including antidepressant use, skipping breakfast, and paternal diet.
  • Monday, June 17
    Endocrine-Disrupting Chemicals: New findings on the health impacts of exposure to chemicals like BPA and the common antibacterial chemical triclocarban.
    Clinical Trials: Breakthroughs in regulating the circadian clock in people who are blind and using testosterone to cope with pain and to improve verbal learning and memory.
  • Tuesday, June 18
    Diabetes: Promising work on how factors such as shortened sleep cycles and testosterone replacement affect insulin resistance.